Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Combined SHP2 and ERK inhibition for the treatment of KRA... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Combined SHP2 and ERK inhibition for the treatment of KRAS-driven Pancreatic Ductal Adenocarcinoma
0
Authors
Katrin Ciecielski
25 more
Katrin Ciecielski
•
Antonio Mulero‐Sánchez
23 more
•
Sara Mainardi
Published
December 15, 2021
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Cell Biology
Show all topics
DOI
10.1101/2021.12.14.472574
License
CC-BY-NC-ND
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Preprint Server
Topics
Biology
Cancer Oncology
Medicine
Internal Medicine
Cell Biology
Show all topics
DOI
10.1101/2021.12.14.472574
License
CC-BY-NC-ND
Other Formats
PDF
